ADAsghar Davood

Asghar Davood

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Asghar Davood has a total of 60 co-authors. Here are the top co-authors by number of shared publications:

  • Maryam Iman

    Department of Pharmaceutics, Faculty of pharmacy, Baqiyatallah University of Medical Sciences, Tehran, Iran

    18 shared publications
  • Hamed Shafaroodi

    Department of Pharmacology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran

    8 shared publications
  • Abbas Shafiee

    Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran

    5 shared publications
  • Mohsen Amini

    Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran

    5 shared publications
  • Alireza Nematollahi

    Group in Biomolecular Structure and Informatics, Faculty of Pharmacy, University of Sydney, Sydney, NSW 2006, Australia

    4 shared publications
  • Atefeh Saadabadi

    Department of Medicinal Chemistry, Faculty of Pharmaceutical Sciences, Tehran Islamic Azad Medical Sciences University, Tehran, Iran

    4 shared publications

Latest Publications

  • Design, Synthesis, and Antimicrobial Activity of Novel 1,4-Dihydropyridine-3,5-Dicarboxamides

    by Yasaman Rasouli, Asghar Davood, Soroush Sardari, Yekta Farahani

  • Open Access

    Design, Synthesis and Anticonvulsant Activity of 2 and 5-disubstituted 1,3-dioxoisoindoline

    by Asghar Davood, Maryam Yadavar Nikravesh, Mahsa Hadipour Jahromy, Sepideh Taghizad

    The isoindoline scaffold, a rigid analogue of ameltolide, exhibits notable antiepileptic properties. Here we describe the design, synthesis, and evaluation of nine new isoindoline derivatives prepared by condensation of trimellitic anhydride with various arylamines. Anticonvulsant activity of prepared compounds was assessed in maximal electroshock (MES; tonic seizure) and pentylenetetrazole (PTZ; clonic seizure) seizure models. All compounds significantly attenuated both tonic and clonic seizures; in MES they reduced seizure-induced mortality, while in PTZ they improved seizure frequency and latency. Compounds 3 and 4 showed the highest efficacy, surpassing phenytoin. Structure–activity analysis indicates that bulky ortho-substituents on the N-aryl group, combined with a meta-nitro substituent, enhance anticonvulsant potency.

  • New synthetic derivatives of isoindoline-dione: synthesis, neuroprotection assay and impact on the expression level of oxidative stress-related genes in neuronal-like cell line

    by Abdolrahim Pourparizi, Mina Vazirinia, Fatemeh Pourrajab, Hamid Nadri, Asghar Davood

    PurposeOxidative stress can damage cells and cause age-related illnesses such as Alzheimer's, Parkinson's, and Huntington's. This study looked at newly synthesized isoindole derivatives and their effects on SH-SY5Y as a neuroblastoma cell under oxidative stress through the NRF2 signaling pathway. NRF2 transcription factor plays a vital role in the oxidative stress response and cellular homeostasis.MethodThree isoindoline-dione derivatives were synthesized by reacting phthalic anhydrides with 4-(2-aminoethyl)-1-benzyl piperidine. Their structures were confirmed through FT-IR, NMR, and Mass spectroscopy. The derivatives were then tested on human SH-SY5Y cells under an oxidative stress model induced by hydrogen peroxide (H2O2). The cell viability, ROS levels, protein carbonyl content, and gene expression of NRF2 and phase II antioxidative enzymes were measured after 24 h.ResultsThree isoindoline derivatives (3a-3c) were observed to increase the viability of SH-SY5Y cells by protective against oxidative stress, reducing intracellular reactive oxygen species and carbonylated proteins, and increasing gene expression levels of NRF2 and associated genes such as NQO-1, and GSTK1.ConclusionIsoindoline derivatives demonstrated a neuroprotective effect on SH-SY5Y cells through various neuroprotective mechanisms, although more studies are needed.

  • N-unsubstituted Imidazoles: Design, Synthesis, and Antimicrobial Evaluation

    by Asghar Davood, Yassamin EbrahimiNassimi, Soroush Sardari, Yekta Farmahini Farahani

    Background: All the current antifungal azoles have one substituted nitrogen atom in their imidazole or triazole rings. In this study, eleven imine and amine derivatives of imidazole, in which both nitrogen atoms of the imidazole ring are unsubstituted, were designed and synthesized. Materials and Methods: Imine derivatives were prepared by condensation of imidazole-4-carboxaldehyde with appropriate amines, and then in the next step, using sodium borohydride, the imines were reduced to amine derivatives. Docking studies reveal unsubstituted nitrogen atom of the imidazole ring coordinated well with the heme molecule of the receptor. In vitro, antimicrobial evaluation was tested on Candida albicans, E. coli, and Staphylococcus aureus. Results: Based on the results of the antimicrobial study, compound 10, which contains 4-chlorobenzyl moiety, proved to be the most potent compound against Candida albicans, and it was more active than the reference drug fluconazole and showed comparable activity to amphotericin B. Compounds 10 and 11 and compounds 8, 10 and 11 showed significant responses against E. coli and Staphylococcus aureus respectively. Conclusion: It is concluded that compound 10 can be acted as a new lead compound to find new azoles antifungal.


  • In vivo Analgesic Activity of New N-arylphthalimides Derivatives in Mice

    by Asghar Davood, Atefeh Saadabadi, Porya Torkaman, Ehsan Salehi, Hamed Shafaroodi

    Background: A series of phthalimides related to thalidomide have been studied for analgesic activity in the formalin test. The formalin test was performed in mice in a nociceptive pattern to evaluate analgesic activity. Methods: In this study, nine derivatives of phthalimides were evaluated in terms of exerting analgesic effects in mice. They exerted significant analgesic effects compared to indomethacin and negative control. These compounds were synthesized and characterized by TLC, followed by IR and H1NMR in the previous studies. Two distinct periods of high licking activity were used to analyze both acute and chronic pain. All compounds were compared with indomethacin and carbamazepine as positive control and vehicle as a negative control. Results: All of the tested compounds exhibited significant analgesic activity in both the first and second phases of the test compared to the control group (DMSO), although they did not show more activity than the reference drug (indomethacin) but were comparable to indomethacin. Conclusion: This information may be useful in the development of a more potent phthalimide as an analgesic agent that acts as a sodium channel blocker and COX inhibitor.


  • Pyrrolopyridine and Isoindole as Potential Anticonvulsant Agents: Design, Synthesis, and Pharmacological Evaluation

    by Asghar Davood, Sepideh Taghizad, Khadijeh Behbahaninia, Mahsa Hadipour Jahromy

    Background and Objective: Phthalimide as the rigid form of ameltolide exhibits a phenytoin-like profile of drug-receptor interaction and is active in the MES model and inactive in the PTZ model as anti-epileptic agent. In this research, based on the isosteric replacement, we have reported the design, preparation, and antiepileptic activity of 13 new analogs of pyrrolopyridine and isoindole. Methods: The designed compounds were prepared by condensing 3, 4-pyridine dicarboxylic anhydride or 4-fluorophthalic anhydride with different respective aryl amines. MES and PTZ induced seizure models were done to evaluate the antiepileptic effect of the prepared ligands. Results: The prepared ligands have significantly affect both tonic and clonic seizures. In tonic seizures, the prepared compounds decrease mortality to a significant extent and in clonic seizures showed better frequency and latency significantly. Compounds 9, 12 and 13 were the most potent ligands that were more potent than phenytoin. Conclusion: It is concluded that the best distance between two aryl parts is two bonds and the substitution of the nitro group at the meta position of the phenyl ring is better than para position. Our research group has been investigating this concept for designing newer compounds with better anticonvulsant activity.


  • 2, 5-Disubstituted Phthalimides: Design, Synthesis and Anticonvulsant Activity in scPTZ and MES Models

    by Atefeh Saadabadi, Babak Kohen, Maryam Irandoust, Hamed Shafaroodi, Tara Mohammadpour, Mahdi Rezayat, Asghar Davood

    In this study, fifteenth new 2,5-disubstituted analgouges of phthalimide were designed and synthesized using the appropriate synthetic route to evaluate anticonvulsant activity against the maximal electroshock (MES) and subcutaneous pentylenetetrazole (scPTZ) compare to phenytoin as a positive control. The structures of the synthesized compounds were confirmed by FT-IR, H-NMR, C-NMR and MASS spectroscopy. All the tested compounds were found to be effective in the PTZ model at the dose of 60 mg/kg and most of the compounds showed protection against MES test indicative of their ability to inhibit the seizure spread at the all dose ranges. Compound 3 has illustrated the best efficacy among all compounds and showed more potency than phenytoin in clonic seizure and was potent as phenytoin in tonic seizure. Using a model of the Na channel, these derivatives were docked in the active site. Docking studies displayed that all synthesized compounds have more negative binding energy compare to reference drug and inhibition-constant less than phenytoin that means they can block the receptor more efficiently and usually form hydrophobic interactions or hydrogen binding interaction frequently with the domains I, II, III and rarely with domain IV.


  • Hybrid Docking-QSAR Studies of 1, 4-dihydropyridine-3, 5-Dicarboxamides as Potential Antitubercular Agents

    by Yasaman Rasouli, Asghar Davood

    Background: Tuberculosis is one of the main medical problems and some people are suffering still from this infectious disease. 1, 4-dihydropyridines are multi-target ligands that recently are recognized as anti-tubercular agents. Method: In the current research, computational studies were conducted of some synthesized 1, 4- dihydropyridine-3, 5-dicarboxamides in non-hydrolyzed and hydrolyzed forms to find the drugreceptor interactions profile. Results: Among equations obtained for non-hydrolyzed compounds, the model with better statistical parameters such as R2= 0.9462, q2 of LOO= 0.8318 and q2 of LMO= 0.7987 was considered as the best one and EEig08d, LAI, Mor23m, GATS3e, Mor28m descriptors were identified as the most significant factors that affect the biological activity of non-hydrolyzed compounds. Conclusion: In the hydrolyzed compounds, the model which has R2= 0.9731, q2 of LOO= 0.91154462 and q2 of LMO= 0.742 was considered as the best one and Mor27e and BEHv2 were also revealed as the most important descriptors in hydrolyzed compounds.


  • Synthesis, In Silico and In Vitro Cytostatic Activity of New Lipophilic Derivatives of Hydroxyurea

    by Zeynab Khansefid, Asghar Davood, Maryam Iman, Mahdi Fasihi

    Background: Hydroxyurea (HU) is used to treat cancer. HU has a short half-life due to its small molecular weight and high polarity, therefore a high dosage of the drug should be used which introduces side effects and more rapid development of resistance. Objective: The objective of the current study is to design new lipophilic analogues of hydroxyurea with higher stability and better cell penetration. The designed compounds were synthesized and then evaluated in terms of their cytostatic activities against two human cell lines. Methods: The synthesis of designed ligands was achieved via two-step procedure. Detail of the synthesis and chemical characterization of the analogs are described. The cytotoxic activity of the designed ligands was evaluated in vitro against two different cancer cell lines at 24 and 48h using MTT test. Results: Based on the IC50 values, all the designed and prepared compounds were more potent than hydroxyurea at 24 and 48h on both cell lines that the cytostatic activity at 48h was more than 24h. Drug-receptor interactions study indicated compound 7 as the most potent ligand, tightly bonded to surrounding amino acids in the active site of receptor via two strong hydrogen bonds and some hydrophobic interactions. Conclusion: Compound 7 with the suitable volume, log p and shape is the most active ligand against both cell lines. It is concluded or suggested that the size, shape and hydrophobic character of substituents strongly affect the pharmacodynamics and pharmacokinetics of these type of ligands.


    • 1 June 2017
      • Vol. 16  (3) , 893-903
    Open Access

    Anticonvulsant Effects of New 1, 4-DihydropyridineDerivatives Containing Imidazolyl Moiety Against Seizures Induced by Pentylenetetrazole and Maximal Electroshock in Mice

    by Yasaman Rasouli, Asghar Davood, Armin Alaee, Golnoush Dehqani, Hamed Shafaroudi, Mahboubeh Lotfinia, Mohsen Amini, Abbas Shafiee

    Epilepsy is a chronic disorder of the brain affecting around 50 million people in the world. Up to 30% of epileptic patients do not respond to available drugs and medical therapies. In this paper, anticonvulsant screening of 10 synthesized new derivatives of 1, 4-dihydropyridine-3, 5-dicarboxamides was performed. Anticonvulsant activity was evaluated by intravenous and intraperitoneal pentylenetetrazole and maximal electroshock induced seizures tests. Nifedipine was used as reference drug. Our pharmacological results revealing the compounds 2, 4, 5, and 6 can be effective in both absence and grandmal seizures in human. These pharmacological studies have displayed that these new dihydropyridine derivatives are capable to inhibiting seizures induced by pentylenetetrazole and maximal electroshock in mice efficiently.